Search research articles
Contact Us
Filters
Showing results (161-170 of 178) with videos related to
Page
of 18
Sort By:
Cell Host & Microbe
|
January 11, 2024
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant
Thomas R Müller, Yu Gao, Jinghua Wu, et al.
Blood Advances
|
October 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
Aishath Naeem, Filippo Utro, Qing Wang, et al.
The Journal of Clinical Investigation
|
August 9, 2014
Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model
Burcu Bestas, Pedro M D Moreno, K Emelie M Blomberg, et al.
RSC Chemical Biology
|
April 2, 2025
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in <i>BTK</i>/<i>Tec</i> double deficient X-linked agammaglobulinemia model
Burcu Bestas, H Yesid Estupiñán, Qing Wang, et al.
Science Translational Medicine
|
July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Thomas R Müller, Takuya Sekine, Darya Trubach, et al.
Nucleic Acids Research
|
January 20, 2011
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo
Samir E L Andaloussi, Taavi Lehto, Imre Mäger, et al.
Journal of Clinical Immunology
|
November 15, 2025
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study
Caroline Stenlander, Hannes Lindahl, Emelie Wahren-Borgström, et al.
Ebiomedicine
|
December 3, 2021
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Peter Bergman, Ola Blennow, Lotta Hansson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 26, 2025
Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patients
Gerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Journal of Human Immunity
|
December 5, 2025
Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patients
Gerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 178) with videos related to
Sort By:
Page
of 18
Cell Host & Microbe
|
January 11, 2024
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant
Thomas R Müller, Yu Gao, Jinghua Wu, et al.
Blood Advances
|
October 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
Aishath Naeem, Filippo Utro, Qing Wang, et al.
The Journal of Clinical Investigation
|
August 9, 2014
Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model
Burcu Bestas, Pedro M D Moreno, K Emelie M Blomberg, et al.
RSC Chemical Biology
|
April 2, 2025
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in <i>BTK</i>/<i>Tec</i> double deficient X-linked agammaglobulinemia model
Burcu Bestas, H Yesid Estupiñán, Qing Wang, et al.
Science Translational Medicine
|
July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Thomas R Müller, Takuya Sekine, Darya Trubach, et al.
Nucleic Acids Research
|
January 20, 2011
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo
Samir E L Andaloussi, Taavi Lehto, Imre Mäger, et al.
Journal of Clinical Immunology
|
November 15, 2025
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study
Caroline Stenlander, Hannes Lindahl, Emelie Wahren-Borgström, et al.
Ebiomedicine
|
December 3, 2021
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Peter Bergman, Ola Blennow, Lotta Hansson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 26, 2025
Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patients
Gerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Journal of Human Immunity
|
December 5, 2025
Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patients
Gerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Page
of 18